Approval · Notice of Compliance 25096 · 2021
EZETIMIBE: Notice of Compliance 25096
Issued January 28, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25096
- Date
- January 28, 2021
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the label and package insert
- Canadian reference product
- EZETROL (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EZETIMIBE | Not yet assigned | — |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB